World / Health & Beauty
California Pharmacies Expect Disaster After Loss In Lawsuit Loss To Stop The 10 Percent Medi-Cal Provider Cuts
07.07.2008 04:18
medicalnewstoday.com
Today, a state court denied eight retail pharmacies' motion to stop the ten percent Medi-Cal provider cuts. The pharmacies sought a temporary restraining order (TRO) from Sacramento Superior Court against the California Department of Health Care Services and its director Sandra Shewry to block the cuts from being implemented.
World
Pharmaceutics
Duchenne Muscular Dystrophy Appears Not To Qualify For Specific Ring Fenced UK Government Funding To Find A Cure
07.07.2008 04:17
medicalnewstoday.com
Funding for Duchenne Muscular Dystrophy, a severe muscle wasting disease that affects boys and young men, was discussed in Parliament this week. Nigel Evans, MP for Ribble Valley, raised the issue of 'ring-fenced' funding for research into treatments and a cure for Dunchenne Muscular Dystrophy and called for more localised specialist care for boys and young men living with the condition.
World
Neurology
Motor Neurone Disease Association Launches Pioneering Tool For Health Care Commissioners In Westminster, UK
07.07.2008 04:17
medicalnewstoday.com
The Motor Neurone Disease (MND) Association has just launched a pioneering tool for health care commissioners in Westminster. It has already been cited as a very important document for patient care and aims to help achieve Lord Darzi's vision of quality care for people living with the complex, and often rapidly progressive neurological condition, MND.
World
Neurology
Campaigners Warn G8 Not To Renege On AIDS Commitments
07.07.2008 04:17
medicalnewstoday.com
Amid fears that critical AIDS pledges made at previous G8 summits will be reneged at this year's meeting in Japan, over 200 civil society organisations from more than 60 countries have signed a letter to G8 heads of state underscoring the fundamental need to fulfil the promise of universal access to prevention, treatment, care and support by 2010.
World
HIV/AIDS
Therapeutic Prescribing Rule Changes - General Optical Council, UK
07.07.2008 04:17
medicalnewstoday.com
Members agreed amendments to the GOC Registration Rules that will create a new Independent Prescribing specialty. The amendments follow changes to medicines legislation which enables optometrists to independently prescribe medicines for the treatment of some ocular conditions. The new legislation came into force 4 June 2008.
World
Eyesight Disorders
Remuneration Arrangements For New Council Agreed - General Optical Council, UK
07.07.2008 04:17
medicalnewstoday.com
At its July meeting Council agreed revised remuneration packages for new Council members who will take up office in April 2009. Members currently receive a daily rate for attendance at Council meetings and other committee or working groups. The chair receives an annual honorarium; the deputy chair, treasurer and committee chairs also receive an annual fee for their additional responsibilities.
World
Eyesight Disorders
Standard Of Proof: Changes To Fitness To Practise Rules Agreed - General Optical Council, UK
07.07.2008 04:17
medicalnewstoday.com
Council members agreed the process and draft timetable for amending the GOC Fitness to Practise Rules to apply the civil standard of proof. As a consequence of the Health and Social Care Bill (expected to become law this month), all nine UK healthcare regulatory bodies will be required to apply the civil standard of proof in their fitness to practise (disciplinary) proceedings.
World
Eyesight Disorders
Dentists And Dental Care Professionals Must Act To Protect Children And Vulnerable Adults, Says General Dental Council, UK
07.07.2008 04:17
medicalnewstoday.com
Dentists and dental care professionals (DCPs) are well placed to identify possible abuse or neglect of children or vulnerable adults - and have a responsibility to raise their concerns if they do, says the GDC. All registrants should know who - a local health trust or board, for example - to contact for advice if they have concerns about potential abuse or neglect, says the GDC in a new statement on child protection.
World
Dentistry
RegeneRx Completes Enrollment And Dosing Of Phase IA Safety Trial For Potential Heart Drug - First Injectable Use Of RGN-352 Tested In Humans
07.07.2008 04:17
medicalnewstoday.com
Regenerx Biopharmaceuticals, Inc. announced today that it has completed enrollment and dosing of 40 healthy subjects for its Phase IA clinical trial testing RGN-352, an injectable formulation of Tβ4 for potential use in treating acute myocardial infarction patients (AMI or heart attack). The trial includes four groups of ten subjects each to assess the safety of escalating doses of RGN-352 injected into the blood stream. To date, there have been no significant drug-related adverse events.
World
Cardiology
APP Pharmaceuticals Receives Final Approvals For Additional Dosages Of Granisetron Hydrochloride Injection, USP
07.07.2008 04:16
medicalnewstoday.com
APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Granisetron Hydrochloride Injection, 1 mg/mL, 1 mL single dose, and 1mg/mL, 4mL multiple dose vials, the generic equivalent of Hoffmann-LaRoche's Kytril® Injection.
World
Cancer
British Journalist Takes First Prize In Prestigious Cancer Journalism Award
07.07.2008 04:16
medicalnewstoday.com
Simon Crompton, who writes for British newspaper The Times, has been awarded the European School of Oncology's Best Cancer Reporter Award (BCRA) for 2008. The Award was established by the European School of Oncology (ESO) in 2006 to encourage better quality media coverage of cancer and to recognise the many examples of outstanding cancer journalism.
World
Cancer
Researchers Identify Cancer Preventive Properties In Common Vitamin Supplement
07.07.2008 04:16
medicalnewstoday.com
Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention. Resveratrol is a natural substance found in red wine and red grapes. It is sold in extract form as a dietary supplement at most major drug stores.
World
Cancer
High Tofu Intake Linked To Higher Memory Loss
07.07.2008 04:16
medicalnewstoday.com
People who eat high levels of some soy products, including tofu and other so-called superfoods, may be at an increased risk of memory loss. Loughborough and Oxford scientists, funded by the Alzheimer's Research Trust, worked with Indonesian colleagues to investigate the effects of high soy consumption in 719 elderly Indonesians living in urban and rural regions of Java.
World
Alzheimer's Disease
Men past 40 face fertility problems: researchers
07.07.2008 03:02
reuters.com
BARCELONA (Reuters) - Couples trying to have a baby when the man is over 40 will have more difficulty conceiving than if he is younger, French researchers said on Sunday.
World
Health & Beauty
Teva says higher dose of MS drug no more efficient
07.07.2008 03:02
reuters.com
(Reuters) - Teva Pharmaceutical Industries Ltd said data from a late-stage trial showed an increased dose of its multiple sclerosis drug, glatiramer acetate (GA), was not more efficient than an approved lower-dose version of the drug.
World
Health & Beauty
English